pyrroles has been researched along with Thrombopenia in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.27) | 18.7374 |
1990's | 1 (2.27) | 18.2507 |
2000's | 3 (6.82) | 29.6817 |
2010's | 37 (84.09) | 24.3611 |
2020's | 2 (4.55) | 2.80 |
Authors | Studies |
---|---|
Fu, Q; Jiang, X; Jing, Y; Peng, H; Rexiti, K; Tao, S; Wei, X; Xiong, F | 1 |
Kadoba, K; Mukoyama, H; Murabe, H; Nishimura, K; Saito, R; Waki, D; Yokota, T | 1 |
Broder, MS; Chang, E; Neary, MP; Reddy, SR | 1 |
Blackwood, EM; Cousin, S; DuPree, K; Epler, J; Hamilton, E; Hollebecque, A; Infante, JR; Italiano, A; Lauchle, JO; LoRusso, PM; Lu, X; Mahrus, S; Moein, A; Moore, KN; Murray, ER; Peale, FV; Postel-Vinay, S; Schutzman, JL; Shapiro, GI; Soria, JC; Tagen, M; Tolaney, S; Toulmonde, M | 1 |
Aki, R; Ito, T; Matsushita, Y; Miyake, H; Motoyama, D; Otsuka, A; Sugiyama, T; Tamura, K | 1 |
Cai, W; Chen, YH; Dong, BJ; Huang, JW; Huang, YR; Kong, W; Li, MY; Xue, W; Yuan, YC; Zhang, J; Zhou, LX | 1 |
Adashek, JJ; Bergerot, PG; Boyd, T; Carret, AS; Chhabra, S; Forero-Torres, A; Gartner, EM; Hoimes, CJ; Li, H; Morris, JC; Pal, SK; Smith, DC; Thompson, JA; Vogelzang, NJ; Yu, X | 1 |
Funakoshi, T; Galsky, MD; Latif, A | 1 |
Cataruozolo, PE; Cesari, R; Collier, M; Cortés, J; Curigliano, G; Elias, A; Goldhirsch, A; Huang, X; Kern, KA; Khosravan, R; Pivot, X | 1 |
Casado Herráez, A; Currás Freixes, M; Díaz Pérez, JÁ; Ochagavía Cámara, S | 1 |
Bekaii-Saab, T; Clinton, SK; Grever, MR; Kraut, EH; Martin, LK; Monk, P; Serna, D | 1 |
Battista, K; Buckstein, R; Howson-Jan, K; Ivy, SP; Kovacs, MJ; Oza, AM; Schuh, AC; Storring, JM; Wang, ES; Wang, L; Wells, RA; Xenocostas, A; Yee, KW | 1 |
Arellano, ML; Berger, M; Borthakur, G; Luer, J; Raza, A | 1 |
Bono, P; Donskov, F; Joensuu, H; Peltola, K; Rautiola, J | 1 |
Chen, Y; Hong, S; Luo, S; Tan, M; Wang, S; Zhang, L | 1 |
Chi, Z; Cui, C; Dai, J; Guo, J; Kong, Y; Li, S; Lian, B; Mao, L; Sheng, X; Si, L; Tang, H; Wang, X; Yan, X | 1 |
Basso, U; Bonetti, A; Bracarda, S; Calabrò, F; Capaccetti, B; Cartenì, G; Ciuffreda, L; Fea, E; Ferrari, V; Fly, K; Gasparini, G; Gasparro, D; Hariharan, S; Labianca, R; Lo Re, G; Masini, C; Porta, C; Ruggeri, EM; Sternberg, CN; Tassinari, D; Zhang, K | 1 |
Fujii, Y; Ishiwata, Y; Kihara, K; Nagata, M; Saito, K; Takahashi, H; Takahashi, Y; Yasuhara, M | 1 |
Houzawa, H; Komatsu, Y; Nishida, T; Ohki, E; Togo, K; Toyoshima, Y; Ueda, E; Ueno, N; Yoshida, A | 1 |
Enokida, H; Fujisawa, M; Fukasawa, S; Fukunaga, K; Hara, I; Hashine, K; Hongo, F; Inoue, T; Kato, Y; Kitamura, H; Kubo, M; Low, SK; Matsuda, K; Matsuyama, H; Miki, T; Mushiroda, T; Nakanishi, H; Nishimura, K; Takahashi, A; Tanaka, T; Tatsugami, K; Tomita, Y; Uemura, H | 1 |
Azumi, M; Hashizume, K; Hori, J; Iwata, T; Kakizaki, H; Kita, M; Kobayashi, S; Matsumoto, S; Okazaki, S; Watanabe, M | 1 |
Bergman, PJ; Merrick, CH; Pierro, J; Regan, RC; Schleis, SE; Siedlecki, CT; Sones, EA; Wright, ZM | 1 |
Arai, Y; Ito, A; Kawasaki, Y; Kikuchi, M; Mano, N; Takasaki, S; Yamaguchi, H | 1 |
Baggstrom, MQ; Baker, S; Crawford, JA; Edelman, MJ; Feliciano, J; Gu, L; Hahn, O; Novotny, P; Socinski, MA; Stinchcombe, TE; Vokes, EE; Wang, XF | 1 |
Beniak, J; Kakalejcik, M; Reckova, M | 1 |
Curiel, RE; Motzer, RJ; Patel, PH; Senico, PL | 1 |
Fayyad, R; Figlin, RA; Hariharan, S; Hudes, G; Kempin, S; Motzer, RJ; Schwartz, LH; Wilding, G | 1 |
Andreiuolo, F; Bobos, M; Calderaro, J; Fountzilas, G; Fragkoulidi, A; Kalogera-Fountzila, A; Marselos, M; Nikolaidou, M | 1 |
Aparicio, LM; Calvo, OF; López, MR; Vázquez, DD | 1 |
Ahn, H; Ahn, JH; Hong, B; Hong, JH; Kim, CS; Kim, JE; Lee, DH; Lee, JL; Lee, JS; Na, S; Song, C; Yoo, C | 1 |
Boven, E; Eechoute, K; Gelderblom, H; Guchelaar, HJ; Haanen, JB; Mathijssen, RH; Reyners, AK; van der Veldt, AA; van Erp, NP; Wessels, JA | 1 |
Al-Tourah, AJ; Buckstein, R; Chua, N; Crump, M; Eisenhauer, EA; Foo, AH; Ivy, SP; Kuruvilla, J; Lee, C; Macdonald, DA; Walsh, W | 1 |
Greil, R; Grundbichler, M; Kappacher, A; Mlineritsch, B; Moik, M; Ressler, S; Rosenlechner, S | 1 |
Brown, A; Ginsberg, MS; James, L; Juergens, R; Kris, MG; Krug, LM; Markus, S; Paik, PK; Pietanza, MC; Rizvi, NA; Rudin, CM; Subzwari, S; Takebe, N; Travis, W; Tyson, L | 1 |
Antón-Aparicio, LM; Cassinello, J; Castellano, D; Esteban, E; González-Larriba, JL; Grande, E; Sepúlveda, J | 1 |
Ahn, JB; Bang, YJ; Chung, HC; Hong, MH; Jeung, HC; Kim, HS; Kim, K; Koh, Y; Lee, SH; Rha, SY; Shin, SJ | 1 |
Ahn, H; Ahn, JH; Ahn, S; Ahn, Y; Hong, JH; Kim, CS; Kim, TW; Lee, JL; Park, I; Park, K; Park, S; Song, C | 1 |
Camidge, DR; Chan, E; Chow Maneval, E; Diab, S; Eckhardt, SG; Khosravan, R; Leong, S; Lin, X; Lockhart, AC; Messersmith, WA; Spratlin, J | 1 |
Albersen, A; Hamberg, P; Njo, T; Porcelijn, L; Schilders, J; Zuetenhorst, H | 1 |
Brickman, MJ; Citrin, DL; Dees, EC; Healey, P; Kern, KA; Li, S; Myers, SD; Paolini, J; Wang, Z; Yardley, DA | 1 |
Han, JH; Han, JY; Kim, HJ; Kim, HT; Kim, HY; Kwak, MH; Lee, JS; Lee, YJ; Lim, KY; Yun, T | 1 |
Bondarenko, I; Carrato, A; Christensen, JG; De la Cruz, JA; Jonker, DJ; Korytowsky, B; Lechuga, MJ; Lim, R; Lin, X; Roman, L; Shparyk, Y; Staszewska-Skurczynska, M; Sun, Y; Swieboda-Sadlej, A; Tursi, JM; Van Cutsem, E; Williams, JA | 1 |
Lockhart, JM | 1 |
Conde, E; Duvós, E; González-Ponte, ML; González-Ruiz, M; Gutiérrez-Iñiguez, MA; Olalla, JI | 1 |
3 review(s) available for pyrroles and Thrombopenia
Article | Year |
---|---|
Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis.
Topics: Anemia; Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Neutropenia; Pyrroles; Sunitinib; Thrombocytopenia | 2022 |
Risk of hematologic toxicities in cancer patients treated with sunitinib: a systematic review and meta-analysis.
Topics: Anemia; Angiogenesis Inhibitors; Antineoplastic Agents; Clinical Trials as Topic; Hematologic Diseases; Humans; Incidence; Indoles; Neoplasms; Neutropenia; Publication Bias; Pyrroles; Risk; Sunitinib; Thrombocytopenia | 2013 |
Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Hemorrhage; Humans; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Odds Ratio; Phenylurea Compounds; Piperidines; Pyrimidines; Pyrroles; Quinazolines; Ramucirumab; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sorafenib; Sulfonamides; Sunitinib; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A | 2015 |
21 trial(s) available for pyrroles and Thrombopenia
Article | Year |
---|---|
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Checkpoint Kinase 1; Deoxycytidine; Dose-Response Relationship, Drug; Drug Interactions; Fatigue; Female; Gemcitabine; Half-Life; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Neutropenia; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrroles; Thrombocytopenia; Treatment Outcome | 2018 |
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
Topics: Aged; Anemia; Benzodiazepines; Carcinoma, Renal Cell; CD27 Ligand; Edema; Fatigue; Female; Humans; Immunoconjugates; Kidney Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Pyrroles; Thrombocytopenia | 2019 |
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Fluorouracil; Gemcitabine; Hand-Foot Syndrome; Humans; Indoles; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pyrroles; Sunitinib; Survival Rate; Taxoids; Thrombocytopenia; Triple Negative Breast Neoplasms | 2013 |
A phase I dose escalation and pharmacodynamic study of SU5416 (semaxanib) combined with weekly cisplatin and irinotecan in patients with advanced solid tumors.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Indoles; Irinotecan; Male; Middle Aged; Nausea; Neoplasms; Pyrroles; Thrombocytopenia; Treatment Outcome | 2013 |
Sunitinib malate in patients with intermediate-2 or high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Diarrhea; Drug Administration Schedule; Fatigue; Female; Humans; Indoles; Kaplan-Meier Estimate; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Pyrroles; Remission Induction; Sunitinib; Thrombocytopenia; Treatment Outcome | 2014 |
A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Disease Progression; Female; Humans; Indoles; Male; Middle Aged; Myelodysplastic Syndromes; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Thrombocytopenia; Treatment Outcome | 2014 |
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Asthenia; Carcinoma, Renal Cell; Compassionate Use Trials; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Dysgeusia; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Indoles; Italy; Kaplan-Meier Estimate; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Neutropenia; Pyrroles; Stomatitis; Sunitinib; Thrombocytopenia; Treatment Outcome | 2015 |
Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Asian People; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hand-Foot Syndrome; Humans; Incidence; Indoles; Japan; Male; Middle Aged; Neutropenia; Prognosis; Proportional Hazards Models; Pyrroles; Severity of Illness Index; Sunitinib; Thrombocytopenia; Treatment Outcome | 2015 |
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Double-Blind Method; Drug Eruptions; Fatigue; Female; Humans; Hypertension; Indoles; Intention to Treat Analysis; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Mucositis; Neoplasm Staging; Neutropenia; Platinum Compounds; Pyrroles; Quality of Life; Sunitinib; Survival Rate; Thrombocytopenia | 2017 |
Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cellulitis; Diarrhea; Drug Eruptions; Female; Humans; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sirolimus; Stomatitis; Sunitinib; Thrombocytopenia; Treatment Outcome | 2009 |
Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fatigue; Female; Humans; Indoles; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Neutropenia; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome | 2009 |
A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.
Topics: Aged; Angiogenesis Inhibitors; Anorexia; Area Under Curve; Carcinoma, Squamous Cell; Drug Administration Schedule; Fatigue; Female; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pyrroles; Sunitinib; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A | 2010 |
The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reduction.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Fatigue; Female; Follow-Up Studies; Humans; Indoles; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Pyrroles; Republic of Korea; Sunitinib; Thrombocytopenia; Treatment Outcome | 2010 |
Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Humans; Indoles; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Salvage Therapy; Sunitinib; Thrombocytopenia; Treatment Failure; Tumor Burden | 2011 |
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease Progression; Female; Humans; Indoles; Lung Neoplasms; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Recurrence; Thrombocytopenia; Topotecan | 2011 |
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anemia; Angiogenesis Inhibitors; Castration; Diarrhea; Drug Resistance, Neoplasm; Fatigue; Hand-Foot Syndrome; Humans; Indoles; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome | 2011 |
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neutropenia; Nomograms; Predictive Value of Tests; Pyrroles; Republic of Korea; Risk Factors; Sunitinib; Thrombocytopenia; Treatment Outcome | 2011 |
A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Indoles; Leucovorin; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome | 2012 |
Phase II open-label study of sunitinib in patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Diarrhea; Disease-Free Survival; Fatigue; Female; Humans; Indoles; Middle Aged; Nausea; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome | 2012 |
A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Asthenia; Disease-Free Survival; Female; Humans; Indoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pyrroles; Small Cell Lung Carcinoma; Sunitinib; Thrombocytopenia; Treatment Outcome | 2013 |
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Diarrhea; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Indoles; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome | 2013 |
20 other study(ies) available for pyrroles and Thrombopenia
Article | Year |
---|---|
Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.
Topics: Aged; Arthritis, Rheumatoid; Castleman Disease; Fatal Outcome; Female; Humans; Janus Kinase Inhibitors; Multiple Organ Failure; Piperidines; Pyrimidines; Pyrroles; Thrombocytopenia | 2020 |
Treatment Patterns and Burden of Illness in Patients Initiating Targeted Therapy or Chemotherapy for Pancreatic Neuroendocrine Tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cost of Illness; Everolimus; Humans; Indoles; Middle Aged; Molecular Targeted Therapy; Nausea; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Retrospective Studies; Sunitinib; Thrombocytopenia; Vomiting; Young Adult | 2017 |
Significance of Age in Japanese Patients Receiving Sunitinib as First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: Comparative Assessment of Efficacy and Safety between Patients Aged <75 and ≥75 Years.
Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Disease-Free Survival; Fatigue; Female; Humans; Indoles; Japan; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pyrroles; Retrospective Studies; Sunitinib; Thrombocytopenia; Treatment Outcome | 2018 |
[Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Diarrhea; Disease Progression; Disease-Free Survival; Hand-Foot Syndrome; Humans; Indoles; Kidney Neoplasms; Multivariate Analysis; Neutropenia; Niacinamide; Phenylurea Compounds; Prognosis; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk Factors; Sorafenib; Sunitinib; Thrombocytopenia; Treatment Outcome | 2018 |
Three cases of sporadic medullary thyroid carcinoma in progression treated with sunitinib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Medullary; Combined Modality Therapy; Hand-Foot Syndrome; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Neck Dissection; Neoplasms, Second Primary; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Thrombocytopenia; Thyroid Neoplasms; Thyroidectomy | 2014 |
Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Carcinoma, Renal Cell; Female; Humans; Hypertension; Indoles; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Pyrroles; Retrospective Studies; Sunitinib; Thrombocytopenia; Treatment Outcome | 2016 |
[Genetic polymorphisms of PDGFR associated with thrombocytopenia in Chinese patients with clear-cell metastatic renal cell carcinoma treated with sunitinib].
Topics: Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Genotype; Humans; Indoles; Polymorphism, Genetic; Pyrroles; Receptors, Platelet-Derived Growth Factor; Sunitinib; Thrombocytopenia; Treatment Outcome | 2014 |
Pharmacokinetic-pharmacodynamic analysis of sunitinib-induced thrombocytopenia in Japanese patients with renal cell carcinoma.
Topics: Aged; Antineoplastic Agents; Asian People; Blood Platelets; Carcinoma, Renal Cell; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Indoles; Intestinal Absorption; Japan; Male; Middle Aged; Models, Biological; Platelet Count; Pyrroles; Sunitinib; Thrombocytopenia | 2015 |
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antineoplastic Agents; Asian People; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Renal Cell; Case-Control Studies; Female; Genetic Association Studies; Humans; Indoles; Japan; Kidney Neoplasms; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Single Nucleotide; Pyrroles; Sunitinib; Thrombocytopenia | 2016 |
[Successful Management by Immunoglobulin for Sunitinib-Induced Thrombocytopenia in a Patient with Advanced Metastatic Renal Cell Carcinoma].
Topics: Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Humans; Immunoglobulins; Indoles; Kidney Neoplasms; Male; Pyrroles; Sunitinib; Thrombocytopenia | 2016 |
Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Azotemia; Cat Diseases; Cats; Female; Gastrointestinal Tract; Indoles; Male; Neoplasms; Neutropenia; Pyrroles; Retrospective Studies; Thrombocytopenia | 2017 |
Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma: a case report.
Topics: Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Drug Administration Schedule; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome | 2017 |
Treatment of hemodialyzed patient with sunitinib.
Topics: Anemia; Antineoplastic Agents; Carcinoma, Renal Cell; Coronary Artery Bypass; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Indoles; Male; Middle Aged; Nausea; Nephrectomy; Pyrroles; Remission Induction; Renal Dialysis; Sunitinib; Thrombocytopenia; Treatment Outcome; Vomiting | 2009 |
Renal cell carcinoma: complete response.
Topics: Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Radiography; Smoking; Sunitinib; Thrombocytopenia; Treatment Outcome | 2010 |
Myelosuppression by sunitinib is flt-3 genotype dependent.
Topics: Antineoplastic Agents; fms-Like Tyrosine Kinase 3; Humans; Indoles; Leukopenia; Polymorphism, Genetic; Pyrroles; Sunitinib; Thrombocytopenia | 2010 |
Efficacy of temsirolimus after previous treatment with sunitinib, sorafenib or everolimus in advanced renal cell cancer.
Topics: Aged; Aged, 80 and over; Anemia; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Diarrhea; Disease-Free Survival; Everolimus; Female; Humans; Indoles; Karnofsky Performance Status; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Retrospective Studies; Sirolimus; Sorafenib; Sunitinib; Thrombocytopenia | 2011 |
Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug Administration Schedule; Fatigue; Female; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Sorafenib; Sulfonamides; Sunitinib; Survival Analysis; Thrombocytopenia; Treatment Outcome; Young Adult | 2012 |
Sunitinib-associated pseudothrombocytopenia induced by IgM antibody.
Topics: Humans; Immunoglobulin M; Indoles; Male; Middle Aged; Platelet Aggregation; Pyrroles; Sunitinib; Thrombocytopenia | 2013 |
Tolmetin-induced thrombocytopenia.
Topics: Child, Preschool; Female; Humans; Pyrroles; Thrombocytopenia; Tolmetin | 1982 |
Atorvastatin-induced severe thrombocytopenia.
Topics: Anticholesteremic Agents; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Thrombocytopenia | 1998 |